JP2009542582A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009542582A5 JP2009542582A5 JP2009512671A JP2009512671A JP2009542582A5 JP 2009542582 A5 JP2009542582 A5 JP 2009542582A5 JP 2009512671 A JP2009512671 A JP 2009512671A JP 2009512671 A JP2009512671 A JP 2009512671A JP 2009542582 A5 JP2009542582 A5 JP 2009542582A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- different
- same
- unsubstituted
- linker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 13
- 229910052736 halogen Inorganic materials 0.000 claims 9
- 150000002367 halogens Chemical class 0.000 claims 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 9
- 125000001424 substituent group Chemical group 0.000 claims 9
- 125000005647 linker group Chemical group 0.000 claims 8
- 238000001890 transfection Methods 0.000 claims 8
- 125000000539 amino acid group Chemical group 0.000 claims 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims 7
- 239000003814 drug Substances 0.000 claims 6
- 230000002209 hydrophobic effect Effects 0.000 claims 6
- 150000002632 lipids Chemical class 0.000 claims 6
- 125000002091 cationic group Chemical group 0.000 claims 4
- 229920006395 saturated elastomer Polymers 0.000 claims 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 3
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 3
- 108010001857 Cell Surface Receptors Proteins 0.000 claims 3
- 102000006240 membrane receptors Human genes 0.000 claims 3
- 125000006850 spacer group Chemical group 0.000 claims 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 125000004036 acetal group Chemical group 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 125000004185 ester group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 230000003612 virological effect Effects 0.000 claims 2
- 102000035195 Peptidases Human genes 0.000 claims 1
- 108091005804 Peptidases Proteins 0.000 claims 1
- 239000004365 Protease Substances 0.000 claims 1
- 108091030071 RNAI Proteins 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 150000001408 amides Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000000692 anti-sense effect Effects 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 230000009368 gene silencing by RNA Effects 0.000 claims 1
- 230000009395 genetic defect Effects 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 125000003473 lipid group Chemical class 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0610636.3A GB0610636D0 (en) | 2006-05-30 | 2006-05-30 | Materials and complexes for the delivery of biologically-active material to cells |
| PCT/GB2007/002012 WO2007138324A2 (en) | 2006-05-30 | 2007-05-30 | Materials and complexes for the delivery of biologically-active material to cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009542582A JP2009542582A (ja) | 2009-12-03 |
| JP2009542582A5 true JP2009542582A5 (https=) | 2010-07-22 |
Family
ID=36687924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009512671A Withdrawn JP2009542582A (ja) | 2006-05-30 | 2007-05-30 | 生物活性物質を細胞に送達するための物質および複合体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9399016B2 (https=) |
| EP (1) | EP2035566B1 (https=) |
| JP (1) | JP2009542582A (https=) |
| CA (1) | CA2650510A1 (https=) |
| GB (1) | GB0610636D0 (https=) |
| WO (1) | WO2007138324A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2605990T3 (es) * | 2010-12-29 | 2017-03-17 | F. Hoffmann-La Roche Ag | Conjugados de molécula pequeña para la administración intracelular de ácidos nucleicos |
| JP7105065B2 (ja) | 2014-12-15 | 2022-07-22 | ダイセルナ ファーマシューティカルズ， インコーポレイテッド | リガンド修飾二本鎖核酸 |
| GB201604235D0 (en) * | 2016-03-11 | 2016-04-27 | Ucl Business Plc | Lipids and complexes for the delivery of biologically-active material to cells |
| EP3225246A1 (en) * | 2016-03-31 | 2017-10-04 | Klinikum der Universität München | Synthetic compound for improving efficiency of transfection |
| GB201705653D0 (en) | 2017-04-07 | 2017-05-24 | Ucl Business Plc | Methods and means for imaging |
| GB201718660D0 (en) * | 2017-11-10 | 2017-12-27 | Ucl Business Plc | Improved liposome for mRNA delivery to cells |
| CA3226457A1 (en) * | 2021-07-30 | 2023-02-02 | Amy WALKER | Nanoparticles and peptides for the delivery of cargos to muscle cells |
| EP4124345A1 (en) * | 2021-07-30 | 2023-02-01 | 4basebio UK Ltd | Nanoparticles for muscle delivery |
| WO2025122775A2 (en) * | 2023-12-06 | 2025-06-12 | Cz Biohub Sf, Llc | Method and composition for targeted receptor-mediated programmable macromolecule delivery |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| US5574142A (en) * | 1992-12-15 | 1996-11-12 | Microprobe Corporation | Peptide linkers for improved oligonucleotide delivery |
| US6037329A (en) * | 1994-03-15 | 2000-03-14 | Selective Genetics, Inc. | Compositions containing nucleic acids and ligands for therapeutic treatment |
| CA2204254C (en) * | 1994-11-17 | 2010-02-16 | Stephen Lewis Hart | Internalisation of dna, using conjugates of poly-l-lysine and an integrin receptor ligand |
| GB9711115D0 (en) | 1997-05-29 | 1997-07-23 | Inst Of Child Health | Integrin-targeting vectors having enhanced transfection activity |
| GB0129121D0 (en) * | 2001-12-05 | 2002-01-23 | Ic Vec Ltd | Compound |
| US7598421B2 (en) * | 2002-05-08 | 2009-10-06 | Ucl Biomedica Plc | Materials for the delivery of biologically-active material to cells |
| WO2005117985A2 (en) * | 2004-06-02 | 2005-12-15 | Ucl Biomedica Plc | Lipopolyplex construct with an integrin binding peptide for delivery of nucleic acids, peptides or drugs |
-
2006
- 2006-05-30 GB GBGB0610636.3A patent/GB0610636D0/en not_active Ceased
-
2007
- 2007-05-30 WO PCT/GB2007/002012 patent/WO2007138324A2/en not_active Ceased
- 2007-05-30 CA CA002650510A patent/CA2650510A1/en not_active Abandoned
- 2007-05-30 EP EP07733028.0A patent/EP2035566B1/en not_active Not-in-force
- 2007-05-30 US US12/227,735 patent/US9399016B2/en active Active
- 2007-05-30 JP JP2009512671A patent/JP2009542582A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009542582A5 (https=) | ||
| JP7430713B2 (ja) | 核酸送達のための脂質化カチオン性ペプチド化合物を含む脂質ナノ粒子製剤 | |
| ES2562658T3 (es) | Procedimientos y medios para el salto eficiente del exón 45 en el pre-ARNm de la distrofia muscular de Duchenne | |
| CN107849567B (zh) | 一种siRNA、含有该siRNA的药物组合物和缀合物及它们的应用 | |
| CN101874112B (zh) | 特别是作为免疫刺激剂/佐剂的式(I)：GlXmGn或式(II)：ClXmCn的核酸 | |
| ES2952644T3 (es) | Compuesto adyuvante | |
| US20170362609A1 (en) | AMPHIPHILIC NANOPARTICLES FOR CODELIVERY OF WATER-INSOLUBLE SMALL MOLECULES AND RNAi | |
| US20130121988A1 (en) | Nucleic Acid of Formula (I): GlXmGn, or (II): ClXmCn, in Particular as an Immune-Stimulating Agent/Adjuvant | |
| TWI685347B (zh) | 用於在活體中遞送ＲＮＡｉ觸發子至腫瘤細胞之聚結合物 | |
| JP2014515762A5 (https=) | ||
| JP2019504002A5 (https=) | ||
| JP7419268B2 (ja) | 変異ｋｒａｓ配列及び脂質を含む化合物並びにその使用 | |
| AU2015269053A1 (en) | Polynucleotide constructs having bioreversible and non-bioreversible groups | |
| JPWO2020219941A5 (https=) | ||
| EP2810661A3 (en) | Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids | |
| JP2011006428A5 (https=) | ||
| WO2008010463A1 (en) | Polymer conjugate of combretastatin | |
| JP2021502346A5 (https=) | ||
| JP2022087209A (ja) | Ｂ型肝炎を治療するための治療用組成物及び方法 | |
| CA3149641A1 (en) | Lipidated cationic peptide-peg compositions for nucleic acid delivery | |
| TWI876778B (zh) | 用於傳遞核酸的基於環烷的脂質化合物以及包括其之脂質奈米粒子 | |
| JPWO2019013255A1 (ja) | 核酸送達用組成物及び核酸含有組成物 | |
| JP2024512770A (ja) | 遺伝子送達における非ウイルスベクターとしての樹状構造 | |
| US9867845B2 (en) | Vectors for delivery of agents across biological membranes | |
| JP6564361B2 (ja) | 核酸送達のための組成物 |